AbbVie to Acquire Apogee for $10.9 Billion to Strengthen Immunology Drug Pipeline
On June 22, local time, U.S. pharmaceutical company AbbVie announced it would acquire biotechnology ...
Ascentage Pharma and K2 Reach Approximately $960 Million License Agreement for ATG-106
Ascentage Pharma Group and K2 Therapeutics have entered into an exclusive license agreement for a pr...
Spanish Team Discovers OLE Molecule Can Restore Microglial Function and Improve Cognition in Alzheimer's Disease
A research team from the Institute of Neuroscience at the Spanish National Research Council - Miguel...
China Approves World's First Solid Tumor CAR-T: CARsgen's Satri-cel for Market
The National Medical Products Administration (NMPA) has approved, through a priority review and appr...
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, a deal aimed at strengthening th...
China's Ministry of Commerce Supports Foreign Investment in High-Quality Development of the Pharmaceutical Industry
Recently, China's Ministry of Commerce, together with the National Development and Reform Commission...
Sylvester Cancer Center in the U.S. Discovers New Pancreatic Cancer Target and Initiates Clinical Trial
Pancreatic cancer treatment has a new potential target. Researchers at the Sylvester Comprehensive C...
ChemT Biotechnology Secures $5 Million in Funding to Advance AI-Driven Biomanufacturing Platform
ChemT Biotechnology has announced the completion of a total of $5 million in funding, consisting of ...
Japan Approves Avastin as World's First Treatment for Neurofibromatosis Type 2
The Japanese Ministry of Health, Labour and Welfare has approved bevacizumab (Avastin) as an additio...
US-based Boltz Partners with Takeda to Deploy Biomolecular AI Models
Boltz PBC, a US-based applied AI research lab, announced on June 18, 2026, a collaboration with Take...